Hester Biosciences rises on getting nod to raise funds up to Rs 100 crore

13 Aug 2018 Evaluate

Hester Biosciences is currently trading at Rs. 1354.00, up by 32.95 points or 2.49% from its previous closing of Rs. 1321.05 on the BSE.

The scrip opened at Rs. 1335.00 and has touched a high and low of Rs. 1360.00 and Rs. 1305.50 respectively. So far 458 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1949.80 on 26-Dec-2017 and a 52 week low of Rs. 845.15 on 23-Aug-2017.

Last one week high and low of the scrip stood at Rs. 1382.90 and Rs. 1270.00 respectively. The current market cap of the company is Rs. 1151.83 crore.

The promoters holding in the company stood at 54.09%, while Institutions and Non-Institutions held 2.42% and 43.49% respectively.

Hester Biosciences has received an approval for issuance of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment for an amount not exceeding Rs 100 crore. The Board of Directors of the company at their meeting held on August 10, 2018, approved the same.

The Board also approved borrowings as a loan to the extent of $10 million under External Commercial Borrowing (ECB) as per guidelines issued by Reserve Bank of India.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Hester Biosciences Share Price

1649.00 17.95 (1.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×